CLINICAL-EVALUATION OF ORAL METHADONE IN TREATMENT OF CANCER PAIN

被引:14
作者
HANSEN, J
GINMAN, C
HARTVIG, P
JAKOBSSON, PA
NILSSON, MI
RANE, A
SAWE, J
ANGGARD, E
机构
[1] HUDDINGE HOSP,KAROLINSKA INST,DEPT ADDICT RES,S-14186 HUDDINGE,SWEDEN
[2] HUDDINGE HOSP,KAROLINSKA INST,DEPT CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN
[3] UNIV UPPSALA HOSP,HOSP PHARM,S-75014 UPPSALA,SWEDEN
[4] ULLERAKERS PSYCHIAT HOSP,DEPT RES,UPPSALA,SWEDEN
关键词
D O I
10.1111/j.1399-6576.1982.tb01860.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:124 / 127
页数:4
相关论文
共 10 条
[1]   PHARMACOKINETICS OF METHADONE DURING MAINTENANCE THERAPY - PULSE LABELING WITH DEUTERATED METHADONE IN THE STEADY-STATE [J].
ANGGARD, E ;
NILSSON, MI ;
HOLMSTRAND, J ;
GUNNE, LM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (01) :53-57
[2]   CLINICAL PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF KETOBEMIDONE [J].
BONDESSON, U ;
ARNER, S ;
ANDERSON, P ;
BOREUS, LO ;
HARTVIG, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (01) :45-50
[3]  
EHRNEBO M, 1977, CLIN PHARMACOL THER, V22, P888
[4]  
ETTINGER DS, 1979, CANCER TREAT REP, V63, P457
[5]  
MERESAAR U, 1981, UNPUB EUROP J CLIN P
[6]  
SAWE J, 1981, CLIN PHARMACOL THER, V30, P629
[7]  
SAWE J, 1981, BRIT MED J, V202, P771
[8]  
SULLIVAN HR, 1975, BIOMED MASS SPECTROM, V2, P197
[9]   METHADONE AND ELDERLY [J].
SYMONDS, P .
BRITISH MEDICAL JOURNAL, 1977, 1 (6059) :512-512
[10]  
VALENTINE AS, 1978, ARNER J NURSING DEC, P2055